Implications of Neocytolysis for Optimal Management of Anaemia in Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|106|4|c149-c156

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.106, Iss.4, 2007-06, pp. : c149-c156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

By Spinowitz Bruce S.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2507-2513

Informa Healthcare

Access to resources Recommend Favorite

Heme iron polypeptide for the management of anaemia of chronic kidney disease

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 4, 2015-08 ,pp. : 386-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

By Kwan Jonathan T. C.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 307-311

Informa Healthcare

Access to resources Recommend Favorite

Anaemia Management in Non-Dialysis Chronic Kidney Disease: Flexibility of Target to Target Stability?

By  

Nephron Clin Pract, Vol. 114, Iss. 4, 2010-01 ,pp. : c236-c241

Karger

Access to resources Recommend Favorite

Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD‐ROUTE study

By  

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 601-608

John Wiley & Sons Inc

Access to resources Recommend Favorite